Prefilled Syringes Market Trends: Improving Patient Experience

Recent innovations in drug delivery focused on making therapeutic products more conducive to a patient’s lifestyle are paving the way for a new future of treatment compliance. Advancements in feature-rich sterile injectable devices providing safer and more convenient self-injection delivery forms are enabling patients to continue treatment outside of hospital settings and within outpatient and home environments, leading to positive patient experiences, better adherence to therapy, and improved health outcomes.

Prefilled Syringe platforms are not only gaining adoption as a drug delivery solution for the commercial stage but also for clinical trials, resulting in improved patient retention, shortened duration of the trials, and more impactful study data. In this Q&A, Shawn Cain, Senior VP Development and Manufacturing, and Justin Schroeder, Global VP Technical Services, PCI Pharma Services, discuss the market trends of prefilled syringes as well as the potential for improved treatment compliance and subsequent patient outcomes.